1.18
price up icon11.32%   0.12
 
loading
前日終値:
$1.06
開ける:
$1.06
24時間の取引高:
2.62M
Relative Volume:
1.59
時価総額:
$217.75M
収益:
-
当期純損益:
$-179.82M
株価収益率:
-0.8872
EPS:
-1.33
ネットキャッシュフロー:
$-159.16M
1週間 パフォーマンス:
+23.13%
1か月 パフォーマンス:
+20.59%
6か月 パフォーマンス:
+35.06%
1年 パフォーマンス:
+52.99%
1日の値動き範囲:
Value
$1.0401
$1.23
1週間の範囲:
Value
$0.8451
$1.23
52週間の値動き範囲:
Value
$0.4993
$1.55

Gossamer Bio Inc Stock (GOSS) Company Profile

Name
名前
Gossamer Bio Inc
Name
セクター
Healthcare (1152)
Name
電話
(858) 684-1300
Name
住所
3115 MERRYFIELD ROW, SAN DIEGO, CA
Name
職員
145
Name
Twitter
@GossamerBio
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
GOSS's Discussions on Twitter

GOSS を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
GOSS
Gossamer Bio Inc
1.18 217.75M 0 -179.82M -159.16M -1.33
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
501.15 126.96B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
605.61 65.06B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ARGX
Argen X Se Adr
649.67 37.54B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
259.39 32.56B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
255.77 26.40B 3.81B -644.79M -669.77M -6.24

Gossamer Bio Inc Stock (GOSS) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-06-25 開始されました Oppenheimer Outperform
2024-04-05 再開されました Wedbush Outperform
2023-07-27 ダウングレード UBS Buy → Neutral
2023-03-07 ダウングレード Raymond James Outperform → Mkt Perform
2023-03-01 開始されました Guggenheim Neutral
2022-12-07 ダウングレード Barclays Overweight → Equal Weight
2022-12-07 ダウングレード JP Morgan Neutral → Underweight
2022-12-07 ダウングレード SMBC Nikko Outperform → Neutral
2022-10-20 開始されました Goldman Buy
2022-09-21 開始されました JP Morgan Neutral
2022-09-19 開始されました Wedbush Outperform
2022-04-18 開始されました Raymond James Outperform
2022-04-06 開始されました UBS Buy
2022-01-10 アップグレード SMBC Nikko Neutral → Outperform
2021-11-09 再開されました Cantor Fitzgerald Overweight
2021-09-21 再開されました Piper Sandler Overweight
2020-06-29 開始されました H.C. Wainwright Buy
2020-04-22 開始されました Piper Sandler Overweight
2020-02-27 開始されました Barclays Overweight
2019-12-03 再開されました BofA/Merrill Buy
2019-10-30 開始されました Berenberg Buy
2019-03-05 開始されました Barclays Overweight
2019-03-05 開始されました BofA/Merrill Buy
2019-03-05 開始されました Evercore ISI Outperform
2019-03-05 開始されました SVB Leerink Outperform
すべてを表示

Gossamer Bio Inc (GOSS) 最新ニュース

pulisher
May 02, 2025

Gossamer Bio: Initiating Hold As Late‐Stage Data Nears Inflection (GOSS) - Seeking Alpha

May 02, 2025
pulisher
May 01, 2025

Selling Buzz: Gossamer Bio Inc [GOSS] Chief Medical Officer Aranda Richard sells 1,908 shares of the company - knoxdaily.com

May 01, 2025
pulisher
Apr 30, 2025

Check out these key findings about Gossamer Bio Inc (GOSS) - Sete News

Apr 30, 2025
pulisher
Apr 30, 2025

Geode Capital Management LLC Has $2.04 Million Stock Holdings in Gossamer Bio, Inc. (NASDAQ:GOSS) - Defense World

Apr 30, 2025
pulisher
Apr 29, 2025

Was Gossamer Bio Inc (GOSS)’s session last reading good? - uspostnews.com

Apr 29, 2025
pulisher
Apr 29, 2025

Gossamer Bio Inc (GOSS) Stock: A Year of Declines and Increases - investchronicle.com

Apr 29, 2025
pulisher
Apr 28, 2025

Closing Strong: Gossamer Bio Inc (GOSS) Ends at 1.17, Up 0.86 from Last Close - DWinneX

Apr 28, 2025
pulisher
Apr 28, 2025

Monitoring Gossamer Bio Inc (GOSS) after recent insider movements - knoxdaily.com

Apr 28, 2025
pulisher
Apr 25, 2025

Gossamer Bio Inc (GOSS Stock: A Sea of Opportunity - investchronicle.com

Apr 25, 2025
pulisher
Apr 25, 2025

Gossamer Bio Insider Confidence Rewarded, Stock Hits US$203m Market Cap - simplywall.st

Apr 25, 2025
pulisher
Apr 24, 2025

Taking the lead: Gossamer Bio Inc (GOSS) - Sete News

Apr 24, 2025
pulisher
Apr 23, 2025

Oppenheimer initates Gossamer Bio Inc (GOSS) rating to an Outperform - knoxdaily.com

Apr 23, 2025
pulisher
Apr 23, 2025

GOSS’s price-to-cash ratio: Is it a good investment at the moment? - uspostnews.com

Apr 23, 2025
pulisher
Apr 23, 2025

Stock Performance Spotlight: Gossamer Bio Inc (GOSS) Ends the Day at 0.83, Up by 1.77 - DWinneX

Apr 23, 2025
pulisher
Apr 22, 2025

Pleasing Signs As A Number Of Insiders Buy Gossamer Bio Stock - Yahoo Finance

Apr 22, 2025
pulisher
Apr 19, 2025

The Goldman Sachs Group Has Lowered Expectations for Gossamer Bio (NASDAQ:GOSS) Stock Price - Defense World

Apr 19, 2025
pulisher
Apr 16, 2025

Is Gossamer Bio Inc. (NASDAQ:GOSS) the Best Penny Stock to Invest in Under $1? - Insider Monkey

Apr 16, 2025
pulisher
Apr 15, 2025

11 Best Penny Stocks to Invest in Under $1 - Insider Monkey

Apr 15, 2025
pulisher
Apr 09, 2025

Gossamer Bio, Inc. (GOSS): Among Stocks Under $10 that Will Triple - Insider Monkey

Apr 09, 2025
pulisher
Apr 09, 2025

Nuvation Bio Inc. (NUVB): Among Stocks Under $10 that Will Triple - Yahoo Finance

Apr 09, 2025
pulisher
Apr 09, 2025

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)April 8, 2025 - BioSpace

Apr 09, 2025
pulisher
Apr 08, 2025

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rul - GuruFocus

Apr 08, 2025
pulisher
Apr 08, 2025

Gossamer Bio Announces Inducement Grant Under - MarketScreener

Apr 08, 2025
pulisher
Apr 08, 2025

10 Stocks Under $10 that Will Triple - Insider Monkey

Apr 08, 2025
pulisher
Apr 07, 2025

Hypertension Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies - The Globe and Mail

Apr 07, 2025
pulisher
Mar 31, 2025

Charles Schwab Investment Management Inc. Raises Stock Position in Gossamer Bio, Inc. (NASDAQ:GOSS) - Defense World

Mar 31, 2025
pulisher
Mar 27, 2025

Is Gossamer Bio Inc. (GOSS) the Popular Penny Stock on Robinhood to Watch? - MSN

Mar 27, 2025
pulisher
Mar 27, 2025

Cantor Fitzgerald Comments on Gossamer Bio FY2025 Earnings - Defense World

Mar 27, 2025
pulisher
Mar 26, 2025

Is Gossamer Bio, Inc. (GOSS) The Hot Biotech Stock Under $5? - Insider Monkey

Mar 26, 2025
pulisher
Mar 26, 2025

Gossamer Bio Inc (NASDAQ: GOSS) Analysts Think Could Fell -290.62% From Current Levels - Stocks Register

Mar 26, 2025
pulisher
Mar 23, 2025

Gossamer Bio (GOSS): Among the Penny Stocks With Huge Upside Potential According to Analysts - Yahoo Finance

Mar 23, 2025
pulisher
Mar 23, 2025

Gossamer Bio, Inc. (NASDAQ:GOSS) Position Decreased by Victory Capital Management Inc. - Defense World

Mar 23, 2025
pulisher
Mar 22, 2025

10 Penny Stocks With Huge Upside Potential According To Analysts - Insider Monkey

Mar 22, 2025
pulisher
Mar 21, 2025

10 Hot Biotech Stocks Under $5 - Insider Monkey

Mar 21, 2025
pulisher
Mar 21, 2025

Q1 EPS Estimates for Gossamer Bio Reduced by HC Wainwright - Defense World

Mar 21, 2025
pulisher
Mar 20, 2025

FY2028 EPS Forecast for Gossamer Bio Decreased by Analyst - Defense World

Mar 20, 2025
pulisher
Mar 19, 2025

GOSSAMER BIO Earnings Preview: Recent $GOSS Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 19, 2025
pulisher
Mar 18, 2025

H.C. Wainwright maintains Buy on Gossamer Bio, $10 target By Investing.com - Investing.com South Africa

Mar 18, 2025
pulisher
Mar 18, 2025

H.C. Wainwright maintains Buy on Gossamer Bio, $10 target - Investing.com

Mar 18, 2025
pulisher
Mar 16, 2025

Wedbush Reiterates Outperform Rating for Gossamer Bio (NASDAQ:GOSS) - Defense World

Mar 16, 2025
pulisher
Mar 15, 2025

Gossamer Bio Reports 2024 Financial Results and Progress - TipRanks

Mar 15, 2025
pulisher
Mar 14, 2025

Gossamer Bio Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 14, 2025
pulisher
Mar 13, 2025

Gossamer Bio shares rise on Q4 earnings beat By Investing.com - Investing.com South Africa

Mar 13, 2025
pulisher
Mar 13, 2025

Gossamer Bio shares rise on Q4 earnings beat - Investing.com India

Mar 13, 2025
pulisher
Mar 13, 2025

Gossamer Bio Inc (GOSS) Q4 Earnings: EPS Loss of $0.15 Beats Est - GuruFocus.com

Mar 13, 2025
pulisher
Mar 13, 2025

Gossamer Bio: Q4 Earnings Snapshot - mySA

Mar 13, 2025

Gossamer Bio Inc (GOSS) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Gossamer Bio Inc (GOSS) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Hasnain Faheem
President & CEO
Jun 21 '24
Buy
0.67
372,000
250,282
5,408,073
Giraudo Bryan
COO/CFO
Jun 18 '24
Buy
0.59
100,000
59,110
480,010
Smith Robert Paul JR
Chief Commercial Officer
Jun 17 '24
Buy
0.60
25,000
15,050
25,000
$72.30
price down icon 0.47%
$21.48
price up icon 2.63%
$32.89
price up icon 1.26%
$27.90
price up icon 13.09%
$104.94
price up icon 2.45%
biotechnology ONC
$255.77
price up icon 0.05%
大文字化:     |  ボリューム (24 時間):